Atlas Trials

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

Clinical trial NCT06358638 · RECRUITING

Trial details

NCT number
NCT06358638
Sponsor
Children's National Research Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2024-04-03
Primary completion
2044-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.